氧化三甲胺与老年常见恶性肿瘤关系的研究进展

doi:10.3969/j.issn.1003-9198.2022.01.005

[1] GOLDSTEIN L, FUNKHOUSER D. Biosynthesis of trimethylamine oxide in the nurse shark, Ginglymostoma cirratum[J]. Comp Biochem Physiol A Comp Physiol, 1972, 42(1): 51-57.
[2] MILLER C, CORBIN K, DA COSTA K, et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study[J]. Am J Clin Nutr, 2014, 100(3): 778-786.
[3] UFNAL M, ZADLO A, OSTASZEWSKI R J N. TMAO: a small molecule of great expectations[J]. Nutrition, 2015, 31: 1317-1323.
[4] GRIFFIN L, DJURIC Z, ANGILETTA C, et al. A Mediterranean diet does not alter plasma trimethylamine N-oxide concentrations in healthy adults at risk for colon cancer[J]. Food, 2019, 10(4): 2138-2147.
[5] MITCHELL S M, MILAN A M, MITCHELL C J, et al. Protein intake at twice the RDA in older men increases circulatory concentrations of the microbiome metabolite trimethylamine-N-oxide (TMAO)[J].Nutrients, 2019, 11(9):2207.
[6] COUTINHO-WOLINO K S, DE F CARDOZO L F M, DE OLIVEIRA LEAL V, et al. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?[J]. Eur J Nutr, 2021, 60(7):3567-3584.
[7] KE Y, LI D, ZHAO M, et al. Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress[J]. Free Radic Biol Med, 2018, 116: 88-100.
[8] SUNG H, FERLAY J, SIEGEL R, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[9] BAE S, ULRICH C, NEUHOUSER M, et al. Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study[J]. Cancer Res, 2014, 74(24):7442-7452.
[10] CHHIBBER-GOEL J, SINGHAL V, PARAKH N, et al. The metabolite trimethylamine-N-oxide is an emergent biomarker of human health[J]. Curr Med Chem, 2017, 24(36): 3942-3953.
[11] LIU X, LIU H, YUAN C, et al. Preoperative serum TMAO level is a new prognostic marker for colorectal cancer[J]. Biomark Med, 2017, 11(5): 443-447.
[12] XU R, WANG Q, LI L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat[J]. BMC Genomics, 2015, 16(Suppl 7): S4.
[13] JANEIRO M, RAMÍREZ M, MILAGRO F, et al. Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target[J]. Nutrients, 2018, 10(10):1398.
[14] SUN X, JIAO X, MA Y, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome[J]. Biochem Biophys Res Commun, 2016, 481(1/2): 63-70.
[15] VAN HECKE T, JAKOBSEN L, VOSSEN E, et al. Short-term beef consumption promotes systemic oxidative stress, TMAO formation and inflammation in rats, and dietary fat content modulates these effects[J]. Food Funct, 2016, 7(9): 3760-3771.
[16] LV L, SHEN Z, ZHANG J, et al. Clinicopathological significance of SIRT1 expression in colorectal adenocarcinoma[J]. Med Oncol, 2014, 31(6): 965.
[17] SAMULAK J, SAWICKA A, SAMBOROWSKA E, et al. Plasma trimethylamine-N-oxide following cessation of L-carnitine supplementation in healthy aged women[J]. Nutrients, 2019, 11(6):1322.
[18] ROHRMANN S, LINSEISEN J, ALLENSPACH M, et al. Plasma concentrations of trimethylamine-N-oxide are directly associated with dairy food consumption and low-grade inflammation in a German adult population[J]. J Nutr, 2016, 146(2): 283-289.
[19] DRAPALA A, SZUDZIK M, CHABOWSKI D, et al. Heart failure disturbs gut-blood barrier and increases plasma trimethylamine, a toxic bacterial metabolite[J]. Int J Mol Sci, 2020, 21(17):6161.
[20] JAWORSKA K, HUC T, SAMBOROWSKA E, et al. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite[J]. PLoS One, 2017, 12(12): e0189310.
[21] SÁNCHEZ-ALCOHOLADO L, ORDÓÑEZ R, OTERO A, et al. Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer[J]. Int J Mol Sci, 2020, 21(18):6782.
[22] SINGH G, ZHANG Y, BOINI K, et al. High mobility group box 1 mediates TMAO-induced endothelial dysfunction[J]. Int J Mol Sci, 2019, 20(14):3570.
[23] YOUSUF A, MCVEY D, YE S. TMAO affects DNA organisation[J]. Atherosclerosis, 2021, 331:e66.
[24] TARASHI S, SIADAT S, AHMADI BADI S, et al. Gut bacteria and their metabolites: which one is the defendant for colorectal cancer?[J]. Microorganisms, 2019, 7(11):561.
[25] OELLGAARD J, WINTHER S, HANSEN T, et al. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des, 2017, 23(25): 3699-3712.
[26] BHAT M Y, SINGH L R, DAR T A. Trimethylamine N-oxide abolishes the chaperone activity of α-casein: an intrinsically disordered protein[J]. Sci Rep, 2017, 7(1): 6572.
[27] RAWLA P, SUNKARA T, GADUPUTI V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors[J]. World J Oncol, 2019, 10(1): 10-27.
[28] MORGELL A, REISZ J, ATEEB Z, et al. Metabolic characterization of plasma and cyst fluid from cystic precursors to pancreatic cancer patients reveal metabolic signatures of bacterial infection[J]. J Proteome Res, 2021, 20(5):2725-2738.
[29] HUANG J, LUU H, BUTLER L, et al. A prospective evaluation of serum methionine-related metabolites in relation to pancreatic cancer risk in two prospective cohort studies[J]. Int J Cancer, 2020, 147(7): 1917-1927.
[30] YANG S, LI X, YANG F, et al. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target[J]. Front Pharmacol, 2019, 10: 1360.
[31] LIU Z, TAN X, LI Q, et al. Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study[J]. Nutr Metab: Lond, 2018, 15: 81.
[32] CHEN S, HENDERSON A, PETRIELLO M, et al. Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction[J]. Cell Metab, 2019, 30(6): 1141-1151.e5.
[33] WU D, CAO M, PENG J, et al. The effect of trimethylamine N-oxide on helicobacter pylori-induced changes of immunoinflammatory genes expression in gastric epithelial cells[J]. Int Immunopharmacol, 2017, 43: 172-178.
[34] YU H J, GENG W C, ZHENG Z, et al. Facile fluorescence monitoring of gut microbial metabolite trimethylamine -oxide via molecular recognition of guanidinium-modified calixarene[J]. Theranostics,2019, 9(16): 4624-4632.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	CAI Hui, WANG Qing, HU Jincao, WANG Yan, HAN Xiaoling. Effects of accelerated rehabilitation with eight section brocade on early ambulation in elderly gastric cancer patients [J]. Practical Geriatrics, 2024, 38(10): 1034-1038.
[2]	. [J]. Practical Geriatrics, 2024, 38(10): 1064-1065.
[3]	. [J]. Practical Geriatrics, 2024, 38(5): 509-437.
[4]	YAO Cui, DING Lingyu, HU Jieman, SUN Yueming. Predictive value of absolute and relative grip strength for postoperative complications in elderly patients with colorectal cancer [J]. Practical Geriatrics, 2024, 38(3): 317-321.
[5]	FENG Jiangzhou, SUN Xiaoxing, JI Xiaojuan, GE Hongfeng. Analysis of efficacy and safety of azacytidine combined with homoharringtonine in treatment of chronic myelomonocytic leukemia [J]. Practical Geriatrics, 2024, 38(2): 145-148.
[6]	LI Jiajia, WANG Mei, WU Changmei, GENG Lan. Predictive value of different nutritional indexes on postoperative frailty in elderly patients with gastrointestinal tumors [J]. Practical Geriatrics, 2024, 38(2): 157-161.
[7]	ZHAO Yuzhe, WU Tianqi, ZHAO Yiran, NING Dianbin. Correlation between ultrasonic imaging features and molecular subtypes of elderly breast cancer [J]. Practical Geriatrics, 2024, 38(2): 166-170.
[8]	ZHU Wugang, ZHAI Chentong, LIU Degan, XU Wenjing. Predictive value of peripheral blood neutrophil to lymphocyte ratio on prognosis for elderly patients with metastatic esophageal cancer after immunotherapy [J]. Practical Geriatrics, 2024, 38(2): 171-175.
[9]	. [J]. Practical Geriatrics, 2024, 38(2): 205-209.
[10]	. [J]. Practical Geriatrics, 2024, 38(2): 210-216.
[11]	. [J]. Practical Geriatrics, 2023, 37(12): 1246-1248.
[12]	QIU Tian-zhu, XU You-tao, LI Xiao-lin, ZHANG Hao. Efficacy of camrelizumab plus chemotherapy for advanced esophageal squamous cell carcinoma in the elderly [J]. Practical Geriatrics, 2023, 37(11): 1107-1110.
[13]	WANG Tian, YE Jin-jun, LI Hui, SHI Shu-tong, ZHANG Zhi, ZHOU Guo-ren, WANG Qiang, ZHANG Rong-rong, HE Xia. Correlation of NLR and PLR before immune consolidation therapy with prognosis in elderly patients with stage Ⅲ non-small cell lung cancer [J]. Practical Geriatrics, 2023, 37(11): 1120-1124.
[14]	LIANG An-shi, XIE Cai-ye. Predictive value of C-reactive protein to albumin ratio combined with neutrophil to lymphocyte ratio for postoperative cognitive dysfunction in elderly patients undergoing radical cystectomy for bladder cancer [J]. Practical Geriatrics, 2023, 37(11): 1125-1129.
[15]	AI Ying, YANG Ya-nan, MENG Li-hua, LYU Jian-rui. Clinical application of improved frailty index to predict complications after radical prostatectomy assisted by robot in elderly patients [J]. Practical Geriatrics, 2023, 37(11): 1143-1146.